New avenues for cancer immunotherapy: Cell-mediated drug delivery systems.

导出 LinkOut

翻译打印收藏纠错

作者： Huan,Zhang ^[1] ; Adam,Grippin ^[2] ; Man,Sun ^[1] ; Yifan,Ma ^[2] ; Betty Y S,Kim ^[3] ; Lesheng,Teng ^[1] ; Wen,Jiang ^[4] ; Zhaogang,Yang ^[5]

作者单位： School of Life Sciences, Jilin University, Changchun 130012, China. ^[1] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ^[2] Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ^[3] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: wjiang4@mdanderson.org. ^[4] School of Life Sciences, Jilin University, Changchun 130012, China. Electronic address: zhaogangyang@jlu.edu.cn. ^[5]

关键词 CAR T cell Cell engineering Dendritic cells Erythrocytes Neutrophils

主题词人类(Humans);肿瘤(Neoplasms);免疫疗法(Immunotherapy);药物释放系统(Drug Delivery Systems);动物(Animals);肿瘤微环境(Tumor Microenvironment);抗肿瘤药(Antineoplastic Agents)

DOI 10.1016/j.jconrel.2024.09.037

PMID 39326499

发布时间 2024-10-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交